AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, February 6, 2020

In The News

Undaunted by political and financial headwinds, major players in diagnostics are forging ahead with deals and partnerships in 2020 to expand their footprint in oncology and hematology, as technology advances in genomic and point-of-care assays and in mass spectrometry markets.
In 2020 revisions to its standards of care, the American Diabetes Association (ADA) made additional screening recommendations for women engaging in pregnancy planning, revised individualized A1C targets in children and adolescents with type 1 and type 2 diabetes, and cast a spotlight on new data about A1C’s usefulness as a…
Hospitals often struggle to collect sufficient volumes of blood to adequately identify bloodstream infections like sepsis. Higher blood volumes are often key to organism recovery, leading to a significant increase in the positivity rate in cultures. A solution: engage hospital staff and leadership and partner labs to drive systemwide quality…

Inside AACC

Illicit drugs such as fentanyl are showing up in vaping devices, adding to concerns about the safety profile of electronic cigarettes. The latest issue of Clinical & Forensic Toxicology News (CFTN) delves deep into this topic, providing an overview of vaping trends and deaths associated with vaping fentanyl analogs and…

World View

N-terminal pro-B-type natriuretic peptide (NT-proBNP) already has a role in assessing heart failure, but new research shows this prohormone strongly correlates with all-cause mortality 30 days after noncardiac surgery and works in conjunction with a clinical risk score to boost cardiac risk prediction in these procedures.